{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:20:05Z","timestamp":1780568405535,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,28]]},"DOI":"10.7759\/cureus.38272","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:34:35Z","timestamp":1682746475000},"source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational Real-World Study from India"],"prefix":"10.7759","author":[{"given":"Prabhakar","family":"D","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Gaurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim SS","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, et al.. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2224-60. 10.1016\/S0140-6736(12)61766-8","journal-title":"Lancet"},{"key":"ref2","unstructured":"Non-communicable diseases country profiles 2011. (2020). Accessed. January 23, 2020: https:\/\/apps.who.int\/iris\/handle\/10665\/44704."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and Stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani SS","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, et al.. Heart disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021, 143:e254-743. 10.1161\/CIR.0000000000000950","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney PM","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, et. al.. Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365:217-23. 10.1016\/S0140-6736(05)17741-1","journal-title":"Lancet"},{"key":"ref5","article-title":"Role and relevance of blood pressure variability in hypertension related co-morbidities","volume":"65","author":"Kumar A","year":"2017","unstructured":"Kumar A, Kalmath BC, Abraham G, et al.. Role and relevance of blood pressure variability in hypertension related co-morbidities. J Assoc Physicians India. 2017, 65:83-92.","journal-title":"J Assoc Physicians India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MBP.0b013e328344c713","article-title":"The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine\/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy","volume":"16","author":"Giles TD","year":"2011","unstructured":"Giles TD, Oparil S, Ofili EO, et al.. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine\/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy. Blood Press Monit. 2011, 16:87-95. 10.1097\/MBP.0b013e328344c713","journal-title":"Blood Press Monit"},{"key":"ref7","article-title":"Ambulatory blood pressure monitoring: dippers compared with non-dippers","volume":"5 Suppl 1","author":"White WB","year":"2000","unstructured":"White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit. 2000, 5 Suppl 1:S17-23.","journal-title":"Blood Press Monit"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000473","article-title":"Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes","volume":"3","author":"Fares H","year":"2016","unstructured":"Fares H, DiNicolantonio JJ, O'Keefe JH, Lavie CJ. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016, 3:e000473. 10.1136\/openhrt-2016-000473","journal-title":"Open Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2016.46.2.222","article-title":"Valsartan 160 mg\/amlodipine 5 mg combination therapy versus amlodipine 10 mg in hypertensive patients with inadequate response to amlodipine 5 mg monotherapy","volume":"46","author":"Sung J","year":"2016","unstructured":"Sung J, Jeong JO, Kwon SU, et al.. Valsartan 160 mg\/amlodipine 5 mg combination therapy versus amlodipine 10 mg in hypertensive patients with inadequate response to amlodipine 5 mg monotherapy. Korean Circ J. 2016, 46:222-8. 10.4070\/kcj.2016.46.2.222","journal-title":"Korean Circ J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.157149","article-title":"Morning surge in blood pressure and cardiovascular risk: evidence and perspectives","volume":"56","author":"Kario K","year":"2010","unstructured":"Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010, 56:765-73. 10.1161\/HYPERTENSIONAHA.110.157149","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1753944710380228","article-title":"Efficacy and tolerability of olmesartan\/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control","volume":"4","author":"Parati G","year":"2010","unstructured":"Parati G, Ochoa JE, Ramos C, Hoshide S, Lonati L, Bilo G. Efficacy and tolerability of olmesartan\/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control. Ther Adv Cardiovasc Dis. 2010, 4:301-13. 10.1177\/1753944710380228","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/0044011-200929010-00002","article-title":"Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study","volume":"29","author":"Volpe M","year":"2009","unstructured":"Volpe M, Brommer P, Haag U, Miele C. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig. 2009, 29:11-25. 10.2165\/0044011-200929010-00002","journal-title":"Clin Drug Investig"},{"key":"ref13","article-title":"Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results (Article in Chinese)","volume":"41","author":"Peng GC","year":"2013","unstructured":"Peng GC, Wang YF, Xiao Y, et al.. Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results (Article in Chinese). Zhonghua Xin Xue Guan Bing Za Zhi. 2013, 41:484-7.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-706100946-4","article-title":"Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension","volume":"16","author":"White WB","year":"2003","unstructured":"White WB, Saunders E, Noveck RJ, et. al.. Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. Am J Hypertens. 2003, 16:739-45. 10.1016\/s0895-706100946-4","journal-title":"Am J Hypertens"},{"key":"ref15","article-title":"Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study","volume":"14","author":"Lefebvre J","year":"1998","unstructured":"Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourci\u00e8re Y. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Can J Cardiol. 1998, 14:682-8.","journal-title":"Can J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0086-9","article-title":"Twenty-four-hour ambulatory blood pressure reduction with a perindopril\/amlodipine fixed-dose combination","volume":"33","author":"Nagy VL","year":"2013","unstructured":"Nagy VL. Twenty-four-hour ambulatory blood pressure reduction with a perindopril\/amlodipine fixed-dose combination. Clin Drug Investig. 2013, 33:469-76. 10.1007\/s40261-013-0086-9","journal-title":"Clin Drug Investig"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.02.003","article-title":"Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension","volume":"29","author":"Poldermans D","year":"2007","unstructured":"Poldermans D, Glazes R, Kargiannis S, et al.. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther. 2007, 29:279-89. 10.1016\/j.clinthera.2007.02.003","journal-title":"Clin Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199310000-00002","article-title":"Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension","volume":"22","author":"Coca A","year":"1993","unstructured":"Coca A, Picado MJ, De la Sierra A, Aguilera MT, S\u00e1nchez M, Lluch MM, Urbano-M\u00e1rquez A. Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension. J Cardiovasc Pharmacol. 1993, 22:513-8. 10.1097\/00005344-199310000-00002","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.09.008","article-title":"An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine\/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine\/ramipril (ATAR) study","volume":"30","author":"Miranda RD","year":"2008","unstructured":"Miranda RD, Mion D Jr, Rocha JC, et al.. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine\/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine\/ramipril (ATAR) study. Clin Ther. 2008, 30:1618-28. 10.1016\/j.clinthera.2008.09.008","journal-title":"Clin Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2012.701127","article-title":"Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the \"normotensive non-dipper\" paradox","volume":"30","author":"Hermida RC","year":"2013","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the \"normotensive non-dipper\" paradox. Chronobiol Int. 2013, 30:87-98. 10.3109\/07420528.2012.701127","journal-title":"Chronobiol Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2012.702581","article-title":"Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction","volume":"30","author":"Hermida RC","year":"2013","unstructured":"Hermida RC, Ayala DE, Fern\u00e1ndez JR, Moj\u00f3n A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013, 30:68-86. 10.3109\/07420528.2012.702581","journal-title":"Chronobiol Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2016.04.001","article-title":"Sleep-time blood pressure: unique sensitive prognostic marker of vascular risk and therapeutic target for prevention","volume":"33","author":"Hermida RC","year":"2017","unstructured":"Hermida RC, Ayala DE, Smolensky MH, Fern\u00e1ndez JR, Moj\u00f3n A, Portaluppi F. Sleep-time blood pressure: unique sensitive prognostic marker of vascular risk and therapeutic target for prevention. Sleep Med Rev. 2017, 33:17-27. 10.1016\/j.smrv.2016.04.001","journal-title":"Sleep Med Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06981","article-title":"Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis","volume":"67","author":"Salles GF","year":"2016","unstructured":"Salles GF, Reboldi G, Fagard RH, et al.. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016, 67:693-700. 10.1161\/HYPERTENSIONAHA.115.06981","journal-title":"Hypertension"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2012.70258","article-title":"Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure","volume":"10","author":"Kario K","year":"1997","unstructured":"Kario K, Shimada K. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure. Am J Hypertens. 1997, 10:261-8. 10.3109\/07420528.2012.70258","journal-title":"Am J Hypertens"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.755403","article-title":"Dosing time matters? Nighttime vs. daytime administration of nifedipine gastrointestinal therapeutic system (GITS) or amlodipine on non-Dipper hypertension: a randomized controlled trial of NARRAS","volume":"8","author":"Liu J","year":"2021","unstructured":"Liu J, Su X, Nie Y, Zeng Z, Chen H. Dosing time matters? Nighttime vs. daytime administration of nifedipine gastrointestinal therapeutic system (GITS) or amlodipine on non-Dipper hypertension: a randomized controlled trial of NARRAS. Front Cardiovasc Med. 2021, 8:755403. 10.3389\/fcvm.2021.755403","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm.2019.02.31814","article-title":"Anti-hypertensive efficacy of amlodipine dosing during morning versus evening: a meta-analysis","volume":"20","author":"Luo Y","year":"2019","unstructured":"Luo Y, Ren L, Jiang M, Chu Y. Anti-hypertensive efficacy of amlodipine dosing during morning versus evening: a meta-analysis. Rev Cardiovasc Med. 2019, 20:91-8. 10.31083\/j.rcm.2019.02.31814","journal-title":"Rev Cardiovasc Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/151091-effectiveness-of-amlodipine-in-the-control-of-24-hour-blood-pressure-in-mild-to-moderate-essential-hypertension-a-prospective-multicenter-observational-real-world-study-from-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:22Z","timestamp":1707508582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/151091-effectiveness-of-amlodipine-in-the-control-of-24-hour-blood-pressure-in-mild-to-moderate-essential-hypertension-a-prospective-multicenter-observational-real-world-study-from-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.38272","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}